Unnamed: 0,title,date,stock,sentiment
633532.0,Heat Biologics Announces FDA Clearance Of Investigational New Drug Application For PTX-35,2020-06-08 07:32:00-04:00,HTBX,neutral
633533.0,"Heat Biologics Shares Spike To Near-Pre Market High 'We are making great progress with our #COVID19 vaccine! At this point, we are on track to complete vaccine design and development in July and initiate manufacturing in August'",2020-06-05 09:04:00-04:00,HTBX,positive
633534.0,Heat Biologics Says On Track To Complete Coronavirus Vaccine Development And Initiate Manufacturing In August,2020-06-04 07:38:00-04:00,HTBX,neutral
633535.0,"Heat Biologics Says In 8K It Has Cash, Cash Equivalents And Short-Term Investments Of $35.5M As Of June 1; Says It Believes It Has Sufficient Cash To Fund Operations And Current And Planned Clinical Activities Into Q1 Of 2022",2020-06-01 14:33:00-04:00,HTBX,neutral
633536.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,HTBX,positive
633537.0,Heat Biologics Shares Relatively Quiet On Large Spike In Volume Following Co. Tweet '...we're developing a [coronavirus] vaccine candidate targeted at helping seniors...',2020-05-28 11:04:00-04:00,HTBX,positive
633538.0,Heat Biologics Announces Collaboration With Waisman Biomanufacturing To Manufacture COVID-19 Coronavirus Vaccine,2020-05-27 08:02:00-04:00,HTBX,neutral
633539.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses.,2020-05-26 11:58:00-04:00,HTBX,positive
633540.0,Heat Biologics Wins US Patent Titled 'Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins',2020-05-26 10:36:00-04:00,HTBX,positive
633541.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,HTBX,neutral
633542.0,"Heat Biologics Q1 EPS $(0.110) Up From $(0.170) YoY, Sales $901.000K Up From $701.062K YoY",2020-05-15 09:35:00-04:00,HTBX,neutral
633543.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-15 07:33:00-04:00,HTBX,neutral
633544.0,Heat Biologics Shares Rebound Slightly From Low Following Co. Tweet 'Our #COVID19 vaccine candidate and #CancerTherapy development are both designed to stimulate the #ImmuneSystem to attack disease-related material...',2020-05-14 10:02:00-04:00,HTBX,negative
633545.0,Heat Biologics Granted Patent Titled 'Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins',2020-05-12 10:00:00-04:00,HTBX,positive
633546.0,Heat Biologics Shares Spike To Session High Following Co. Tweet 'We are happy to announce significant progress on our #COVID19 efforts and anticipated milestones for our vaccine...',2020-05-01 11:01:00-04:00,HTBX,positive
633547.0,"Heat Biologics Highlights Anticipated Q2 Coronavirus Vaccine Candidate Milestones Including Completion Of Development, Generation Of Proof Of Concept Data And Submission Of Grant Applications",2020-04-29 08:09:00-04:00,HTBX,positive
633548.0,Heat Biologics 8-K Reports Collaboration With University Of Miami For Development Of Coroanvirus Point-Of-Care Diagnostic Has Been Terminated,2020-04-28 08:41:00-04:00,HTBX,neutral
633549.0,81 Biggest Movers From Friday,2020-04-27 05:33:00-04:00,HTBX,neutral
633550.0,54 Stocks Moving In Friday's Mid-Day Session,2020-04-24 12:22:00-04:00,HTBX,neutral
633551.0,32 Stocks Moving in Friday's Pre-Market Session,2020-04-24 07:11:00-04:00,HTBX,neutral
633552.0,Heat Biologics Inc Files For Mixed Shelf Of Up To $150M,2020-04-23 16:48:00-04:00,HTBX,neutral
633553.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-04-23 07:31:00-04:00,HTBX,neutral
633554.0,31 Stocks Moving in Tuesday's Pre-Market Session,2020-04-14 07:10:00-04:00,HTBX,neutral
633555.0,Heat Biologics Tweets Link To Check Out Co.'s Pipeline Of Work In Cancer,2020-04-13 10:06:00-04:00,HTBX,negative
633557.0,Heat Biologics Announces Formation Of Coronavirus Advisory Board,2020-04-01 08:02:00-04:00,HTBX,neutral
633558.0,"Heat Biologics Shares Up 6% Following FY19 Results; BZ NOTE: In Earnings Press Release, Co. Mentioned 'Update' On Development Of Its gp96 Vaccine For Coronavirus, 'Progress' On Its Coronavirus Test, However Specifics Of Update/Progress Were Not Mentioned",2020-03-30 08:41:00-04:00,HTBX,positive
633559.0,Heat Biologics FY19 EPS $(0.60) vs $(0.90) In FY18,2020-03-30 08:35:00-04:00,HTBX,neutral
633560.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-03-26 07:39:00-04:00,HTBX,neutral
633561.0,31 Stocks Moving in Thursday's Pre-Market Session,2020-03-26 07:10:00-04:00,HTBX,neutral
633562.0,Heat Biologics Collaborating with the University of Miami to Develop a Coronavirus Diagnostics Test Which Will Deliver Results Within 30 Minutes,2020-03-23 07:40:00-04:00,HTBX,neutral
633563.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-18 07:46:00-04:00,HTBX,neutral
633564.0,18 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-17 08:58:00-04:00,HTBX,neutral
633565.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-16 08:32:00-04:00,HTBX,neutral
633566.0,Heat Biologics Invited To Join The Alliance For Biosecurity,2020-03-16 08:12:00-04:00,HTBX,positive
633567.0,Heat Biologics Says Engaged Government Relations Firm To Assist In Advancing Collaboration Efforts And Securing Gov. Funding Related To Coronavirus Program,2020-03-11 08:20:00-04:00,HTBX,positive
633568.0,23 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-03-06 07:56:00-05:00,HTBX,neutral
633569.0,101 Biggest Movers From Yesterday,2020-03-06 04:28:00-05:00,HTBX,neutral
633570.0,Heat Biologics CEO Jeff Wolf To Appear On TD At 1:20 p.m. To Discuss Coronavirus Vaccine Platform,2020-03-05 13:10:00-05:00,HTBX,neutral
633571.0,Heat Biologics shares are trading higher after the company announced a research collaboration with University of Miami to develop a coronavirus vaccine.,2020-03-05 12:58:00-05:00,HTBX,positive
633572.0,Hearing Maxim Raised Heat Biologics Price Target From $1 To $2; Unconfirmed,2020-03-05 12:57:00-05:00,HTBX,negative
633573.0,70 Stocks Moving In Thursday's Mid-Day Session,2020-03-05 12:25:00-05:00,HTBX,neutral
633574.0,Heat Biologics Reports Research Collaboration With University Of Miami To Develop Vaccine To Protect Against Coronavirus,2020-03-05 09:02:00-05:00,HTBX,positive
633575.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-03-05 07:51:00-05:00,HTBX,neutral
633576.0,31 Stocks Moving in Thursday's Pre-Market Session,2020-03-05 07:18:00-05:00,HTBX,neutral
633577.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,HTBX,neutral
633578.0,Heat Biologics CEO To Appear Today On ABC11-WTVD To Discuss The Company's Newly Launched Program To Develop Vaccine to Protect Against SARS-CoV-2 Coronavirus That Causes COVID-19,2020-03-04 15:13:00-05:00,HTBX,positive
633579.0,60 Stocks Moving In Wednesday's Mid-Day Session,2020-03-04 12:11:00-05:00,HTBX,neutral
633580.0,36 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-04 08:00:00-05:00,HTBX,neutral
633581.0,38 Stocks Moving in Wednesday's Pre-Market Session,2020-03-04 07:18:00-05:00,HTBX,neutral
633582.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,HTBX,neutral
633583.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-03-03 12:03:00-05:00,HTBX,neutral
633584.0,"Benzinga Pro's Top 6 Stocks To Watch For Tues., Mar. 3, 2020: TGT, BYND, UBER, NOVN, QRVO, HTBX",2020-03-03 08:00:00-05:00,HTBX,positive
633585.0,40 Stocks Moving in Tuesday's Pre-Market Session,2020-03-03 07:31:00-05:00,HTBX,neutral
633586.0,"UPDATE: Maxim Reiterates Buy, $1 Price Target On Heat Biologics",2020-03-02 13:16:00-05:00,HTBX,neutral
633587.0,Heat Biologics Shares Tick Higher Over $0.50 Level; Hearing Maxim Positive On Stock Following Co. Filing Mon. On Patent Application For Immune Therapy/Vaccine Technology,2020-03-02 13:15:00-05:00,HTBX,positive
633588.0,Heat Biologics Rallies On Provisional Coronavirus Patent Application,2020-03-02 11:11:00-05:00,HTBX,neutral
633589.0,30 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-02 07:41:00-05:00,HTBX,neutral
633590.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,HTBX,neutral
633591.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,HTBX,neutral
633592.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,HTBX,negative
633593.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,HTBX,positive
633594.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-26 11:14:00-05:00,HTBX,negative
633595.0,24 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-26 08:01:00-05:00,HTBX,neutral
633596.0,"Maxim Group Earlier Initiated Coverage On Heat Biologics with Buy Rating, Announced $1 Price Target",2020-02-06 13:59:00-05:00,HTBX,neutral
633597.0,Heat Biologics Shares Volatile On Spike In Volume As Traders Circulate US PTO Abstract For 'Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins',2020-01-29 11:03:00-05:00,HTBX,positive
633598.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,HTBX,neutral
633599.0,43 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-28 23:40:00-05:00,HTBX,neutral
633600.0,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics",2020-01-28 07:12:00-05:00,HTBX,positive
633601.0,Stocks That Hit 52-Week Lows On Monday,2020-01-27 10:42:00-05:00,HTBX,negative
633602.0,Stocks That Hit 52-Week Lows On Friday,2020-01-24 11:18:00-05:00,HTBX,negative
633603.0,15 Biotechnology Stocks Moving In Thursday's After-Market Session,2020-01-23 23:28:00-05:00,HTBX,neutral
633604.0,20 Healthcare Stocks Moving In Thursday's After-Market Session,2020-01-23 23:13:00-05:00,HTBX,neutral
633605.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,HTBX,neutral
633606.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,HTBX,neutral
633607.0,"The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares",2020-01-17 08:07:00-05:00,HTBX,negative
633608.0,Heat Biologics Shares Resume Trade,2020-01-16 10:24:00-05:00,HTBX,positive
633609.0,Heat Biologics Shares To Resume Trade At 10:20 a.m. EST,2020-01-16 09:59:00-05:00,HTBX,positive
633610.0,"Heat Biologics Prices 20M Common Stock, Warrants Offering At $0.35/Share",2020-01-16 09:54:00-05:00,HTBX,neutral
633611.0,Heat Biologics Shares Halted News Pending,2020-01-16 09:39:00-05:00,HTBX,positive
633612.0,Heat Biologics Doses the First Patient in its Phase 1 Trial of HS-130,2019-12-16 07:12:00-05:00,HTBX,neutral
633614.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-20 07:45:00-05:00,HTBX,neutral
633615.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,HTBX,neutral
633616.0,"Heat Biologics Q3 EPS $(0.18) Down From $(0.16) YoY, Sales $6.439K Down From $1.84M YoY",2019-11-15 09:12:00-05:00,HTBX,neutral
633617.0,Heat Biologics Presents Phase 2 Interim Data at the Society for Immunotherapy of Cancer Meeting,2019-11-11 07:09:00-05:00,HTBX,negative
633618.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,HTBX,neutral
633619.0,"Heat Biologics Amended S-1 Shows Registration For ~22.64M Common Stock, Common Warrants To Buy 11.3M In Common Shares Offering",2019-11-05 08:20:00-05:00,HTBX,positive
633620.0,Heat Biologics Reports Phase 2 Interim Data In NSCLC Patients Who Previously Failed Checkpoint Inhibitor Treatment,2019-11-05 08:04:00-05:00,HTBX,negative
633621.0,24 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-04 08:13:00-05:00,HTBX,neutral
633622.0,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",2019-11-03 10:51:00-05:00,HTBX,neutral
633623.0,Heat Biologics Highlights Post Presentation Of Updated Top-Line Phase 2 Data Of HS-110 Plus Nivolumab After Checkpoint Inhibitor Treatment Failure In NSCLC Patients At SITC Meeting,2019-10-24 10:05:00-04:00,HTBX,negative
633624.0,"The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch",2019-10-16 07:06:00-04:00,HTBX,positive
633625.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-15 11:05:00-04:00,HTBX,negative
633626.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-10 11:08:00-04:00,HTBX,negative
633627.0,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO",2019-10-10 07:31:00-04:00,HTBX,neutral
633628.0,"The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration",2019-10-08 07:11:00-04:00,HTBX,negative
633629.0,Stocks That Hit 52-Week Lows Of Monday,2019-10-07 11:09:00-04:00,HTBX,negative
633630.0,Stocks That Hit 52-Week Lows On Friday,2019-10-04 14:32:00-04:00,HTBX,negative
633631.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-02 10:55:00-04:00,HTBX,negative
633632.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,HTBX,negative
633633.0,32 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-03 08:42:00-04:00,HTBX,neutral
633634.0,10 Biopharmaceutical Companies Trying To Cure Cancer,2019-08-24 13:46:00-04:00,HTBX,negative
633635.0,Heat Biologics Q2 EPS $(0.14) Up From $(0.26) YoY,2019-08-14 07:38:00-04:00,HTBX,neutral
633636.0,16 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-13 08:36:00-04:00,HTBX,neutral
633637.0,17 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-08-12 08:30:00-04:00,HTBX,neutral
633638.0,Heat Biologics Reports FDA Clearance Of Investigational New Drug Application To Begin Phase 1 Trial Of HS-130 In Combo With HS-110,2019-08-12 07:19:00-04:00,HTBX,neutral
633639.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-01 09:38:00-04:00,HTBX,neutral
633640.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-31 09:41:00-04:00,HTBX,neutral
633641.0,28 Healthcare Stocks Moving In Tuesday's After-Market Session,2019-07-31 04:01:00-04:00,HTBX,neutral
633642.0,"Benzinga's Top Upgrades, Downgrades For July 30, 2019",2019-07-30 09:59:00-04:00,HTBX,positive
633643.0,"Brookline Capital Initiates Coverage On Heat Biologics with Buy Rating, Announces $8 Price Target",2019-07-30 06:45:00-04:00,HTBX,neutral
633644.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,HTBX,neutral
633645.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,HTBX,neutral
633646.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,HTBX,negative
633647.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,HTBX,positive
633648.0,Heat Biologics Completes Enrollment In Phase 2 Non-Small Cell Lung Cancer Trial,2019-07-09 08:22:00-04:00,HTBX,negative
633649.0,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",2019-07-09 07:11:00-04:00,HTBX,positive
633650.0,66 Biggest Movers From Yesterday,2019-06-04 05:19:00-04:00,HTBX,neutral
633651.0,Genocea Biosciences Rallies 50% On ASCO Presentation,2019-06-03 12:47:00-04:00,HTBX,neutral
633652.0,51 Stocks Moving In Monday's Mid-Day Session,2019-06-03 12:46:00-04:00,HTBX,neutral
633653.0,30 Stocks Moving In Monday's Pre-Market Session,2019-06-03 08:12:00-04:00,HTBX,neutral
633654.0,Heat Biologics shares are trading higher after the company announced interim Phase 2 lung cancer data showing that its HS-110 demonstrated clinical activity in tumor patients.,2019-06-03 07:44:00-04:00,HTBX,negative
633655.0,Heat Biologics Announces 'Promising' Interim Phase 2 Lung Cancer Data Suggesting that HS-110 Plus Nivolumab May Restore Clinical Benefit After Checkpoint Inhibitor Treatment Failure,2019-06-03 07:40:00-04:00,HTBX,negative
633656.0,Heat Biologics Shares React Amid Circulation Of PatentScope Doc,2019-05-31 13:52:00-04:00,HTBX,positive
633657.0,Heat Biologics Shares Spike Higher From Session Low As Traders Circulate World Intellectual Property Organization Doc For GP96-Based Cancer Therapy,2019-05-31 12:17:00-04:00,HTBX,negative
633658.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,HTBX,neutral
633659.0,"The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice",2019-05-24 07:44:00-04:00,HTBX,neutral
633660.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,HTBX,negative
633661.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,HTBX,positive
633662.0,Heat Biologics Announces At Market Issuance Sales Agreement For Sale Of Up To $18M Of Shares Of The Company's Common Stock,2019-04-04 06:09:00-04:00,HTBX,positive
633663.0,Heat Biologics Says Fully Funded Through Completion Of HS-110 Phase 2 Trial With Approximately $28M Of Cash And Investments At Year End; Expects Additional $6.9M In Grant Funds In Q2,2019-03-28 07:40:00-04:00,HTBX,positive
633664.0,Heat Biologics Says Remains On Track To Complete Enrollment Of Phase 2 Lung Cancer Trial In Q2 2019 And Report Additional Interim Data In Q4,2019-03-28 07:39:00-04:00,HTBX,negative
633665.0,"Heat Biologics Inc shares are trading lower after the company presented interim Phase 2 Lung Cancer data on HS-110 that stated ""median overall survival not yet reached with median follow up of 14.4 months in Cohort A.""",2019-03-01 11:25:00-05:00,HTBX,negative
633666.0,UPDATE: Heat Biologics Says 'Median overall survival not yet reached with median follow up of 14.4 months in Cohort A',2019-02-28 17:02:00-05:00,HTBX,negative
633667.0,Heat Biologics Reports Interim Phase 2 Lung Cancer Data On HS-110 + Nivolumab At ASCO-SITC Symposium: 'suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior checkpoint inhibitor therapy',2019-02-28 17:01:00-05:00,HTBX,negative
633668.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,HTBX,positive
633669.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Feb. 27, 2019",2019-02-27 09:28:00-05:00,HTBX,positive
633670.0,72 Biggest Movers From Yesterday,2019-02-27 04:55:00-05:00,HTBX,neutral
633671.0,54 Stocks Moving In Tuesday's Mid-Day Session,2019-02-26 12:18:00-05:00,HTBX,neutral
633672.0,Heat Biologics shares are trading higher after an abstract on the company's HS-110 interim phase 2 data was published on the American Society of Clinical Oncology website.,2019-02-26 09:19:00-05:00,HTBX,positive
633673.0,Heat Biologics 8-K Shows Abstract Posted On ASCO-SITC For New HS-110 Interim Phase 2 Data,2019-02-25 17:57:00-05:00,HTBX,neutral
633674.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,HTBX,neutral
633675.0,"The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits",2019-01-10 08:27:00-05:00,HTBX,negative
633676.0,Heat Biologics Principal Investigator Selected To Deliver Oral Presentation Of New HS-110 Interim Phase 2 Data At The 2019 ASCO-SITC Clinical Immuno-Oncology Symposium,2019-01-08 07:36:00-05:00,HTBX,neutral
633677.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2018-12-30 15:27:00-05:00,HTBX,neutral
633678.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,HTBX,neutral
633679.0,The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results,2018-12-23 10:37:00-05:00,HTBX,neutral
633680.0,Heat Biologics 13G Filing From Anson Funds Management Shows New 6.2% Stake,2018-12-03 16:12:00-05:00,HTBX,neutral
633681.0,50 Biggest Movers From Wednesday,2018-11-23 05:17:00-05:00,HTBX,neutral
633682.0,Mid-Afternoon Market Update: Crude Oil Up Over 3%; Qudian Shares Spike Higher,2018-11-21 15:25:00-05:00,HTBX,negative
633683.0,34 Stocks Moving In Wednesday's Mid-Day Session,2018-11-21 12:42:00-05:00,HTBX,neutral
633684.0,Mid-Day Market Update: Foot Locker Gains On Upbeat Earnings; Heat Biologics Shares Plummet,2018-11-21 12:18:00-05:00,HTBX,positive
633685.0,Mid-Morning Market Update: Markets Open Higher; Deere Misses Q4 Expectations,2018-11-21 10:15:00-05:00,HTBX,negative
633686.0,"Heat Biologics Prices 8M Shares, 4M Warrants At $1.50/Unit",2018-11-21 08:56:00-05:00,HTBX,positive
633687.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,HTBX,negative
633688.0,Heat Biologics shares are trading lower after the company announced a common stock and warrant offering. The size was not disclosed.,2018-11-21 08:04:00-05:00,HTBX,neutral
633689.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-11-21 08:01:00-05:00,HTBX,neutral
633690.0,"8 Stocks To Watch For November 21, 2018",2018-11-21 05:31:00-05:00,HTBX,neutral
633691.0,"Heat Biologics shares down 20.5% following news of a common stock and warrants offering, no size disclosed.",2018-11-20 16:57:00-05:00,HTBX,neutral
633692.0,"Heat Biologics Shares Indicated Down 20% After Hours As Co. Earlier Announced Offering Of Common Shares, Warrants, No Size Disclosed",2018-11-20 16:52:00-05:00,HTBX,positive
633693.0,"Heat Biologics Q3 EPS $(0.16) Up From $(0.64) YoY, Sales $1.84M Beat $500K Estimate",2018-11-15 08:19:00-05:00,HTBX,neutral
633694.0,Heat Biologics Offers 5 Recent Highlights From Subsidiary Pelican's Novel PTX-35 T-Cell Costimulator,2018-10-04 07:09:00-04:00,HTBX,positive
633695.0,"Heat Biologics Q2 EPS $(0.27) Down From $(0.09) YoY, Sales $1.143M Up From $411K YoY",2018-08-14 08:06:00-04:00,HTBX,neutral
633696.0,28 Stocks Moving In Monday's Mid-Day Session,2018-07-09 12:16:00-04:00,HTBX,neutral
633697.0,20 Stocks Moving In Monday's Pre-Market Session,2018-07-09 08:48:00-04:00,HTBX,neutral
633698.0,"Benzinga's Top Upgrades, Downgrades For June 26, 2018",2018-06-26 09:06:00-04:00,HTBX,positive
633699.0,"H.C. Wainwright Initiates Coverage On Heat Biologics with Buy Rating, Announces $6 Price Target",2018-06-26 07:04:00-04:00,HTBX,neutral
633700.0,42 Biggest Movers From Yesterday,2018-06-13 05:31:00-04:00,HTBX,neutral
633701.0,41 Stocks Moving In Tuesday's Mid-Day Session,2018-06-12 12:29:00-04:00,HTBX,neutral
633702.0,40 Biggest Movers From Yesterday,2018-06-07 04:50:00-04:00,HTBX,neutral
633703.0,Heat Biologics Shares Up 9% On Heavy Volume; No Apparent News,2018-05-23 15:10:00-04:00,HTBX,neutral
633704.0,33 Stocks Moving In Wednesday's Mid-Day Session,2018-05-23 12:53:00-04:00,HTBX,neutral
633705.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-05-23 08:36:00-04:00,HTBX,neutral
633706.0,"Heat Biologics Q1 EPS $(0.75), Sales $752K Miss $1M Estimate",2018-05-15 07:24:00-04:00,HTBX,negative
633707.0,55 Biggest Movers From Yesterday,2018-05-04 04:41:00-04:00,HTBX,neutral
633708.0,Mid-Afternoon Market Update: Dow Turns Positive; Anika Therapeutics Shares Fall Following Disappointing Q1 Results,2018-05-03 14:34:00-04:00,HTBX,positive
633709.0,37 Stocks Moving In Thursday's Mid-Day Session,2018-05-03 13:39:00-04:00,HTBX,neutral
633710.0,Mid-Day Market Update: Dow Down Over 250 Points; STAAR Surgical Shares Spike Higher,2018-05-03 12:03:00-04:00,HTBX,positive
633711.0,Mid-Morning Market Update: Markets Open Lower; Kellogg Earnings Top Views,2018-05-03 10:26:00-04:00,HTBX,negative
633712.0,55 Biggest Movers From Yesterday,2018-05-03 04:42:00-04:00,HTBX,neutral
633713.0,Mid-Afternoon Market Update: Community Health Systems Surges Following Q1 Beat; TC PipeLines Shares Slide,2018-05-02 15:01:00-04:00,HTBX,positive
633714.0,43 Stocks Moving In Wednesday's Mid-Day Session,2018-05-02 13:30:00-04:00,HTBX,neutral
633715.0,Mid-Day Market Update: Nanometrics Rises On Earnings Beat; Esperion Therapeutics Shares Drop,2018-05-02 12:47:00-04:00,HTBX,neutral
633716.0,Mid-Morning Market Update: Markets Mixed; Apple Earnings Top Expectations,2018-05-02 10:22:00-04:00,HTBX,positive
633717.0,Heat Biologics Sahres Down 30% Premarket; Shares Rallied As Much As ~270% Since Apr. 30; No News To Justify Price Action,2018-05-02 09:09:00-04:00,HTBX,neutral
633718.0,21 Stocks Moving In Wednesday's Pre-Market Session,2018-05-02 08:11:00-04:00,HTBX,neutral
633719.0,42 Biggest Movers From Yesterday,2018-05-02 05:31:00-04:00,HTBX,neutral
633720.0,Mid-Afternoon Market Update: NASDAQ Up 0.5%; Inogen Shares Spike Higher,2018-05-01 15:01:00-04:00,HTBX,positive
633721.0,"Benzinga Pro's Most-Searched Tickers For Afternoon Of May 1, 2018",2018-05-01 14:01:00-04:00,HTBX,neutral
633722.0,32 Stocks Moving In Tuesday's Mid-Day Session,2018-05-01 13:04:00-04:00,HTBX,neutral
633723.0,Mid-Day Market Update: Crude Oil Down 1.8%;  Nutrisystem Shares Climb On Upbeat Earnings,2018-05-01 12:15:00-04:00,HTBX,negative
633724.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results,2018-05-01 10:38:00-04:00,HTBX,negative
633725.0,21 Stocks Moving In Tuesday's Pre-Market Session,2018-05-01 08:32:00-04:00,HTBX,neutral
633726.0,Benzinga Pro's 5 Stocks To Watch Today,2018-05-01 08:24:00-04:00,HTBX,neutral
633727.0,"Heat Biologics Shares Up 51.9% Premarket Following 87.7% Rally On Mon.; Not Seeing News This Morning To Justify Sharp Move Higher; BZ NOTE: Stock May Be Viewed As 'Low-Float' Play, Has ~5.6M Shares Outstanding",2018-05-01 08:20:00-04:00,HTBX,positive
633728.0,Heat Biologics Shares Now Up 122% On No News; BZ NOTE: Momentum May Be Related To Recent Interest In Low-Float Stocks; Heat Biologics Has ~5.6M Shares Outstanding,2018-04-30 13:27:00-04:00,HTBX,positive
633729.0,"Heat Biologics Shares Resume Trade, Pullback From Session Highs, Now Up 79.8%",2018-04-30 13:24:00-04:00,HTBX,positive
633730.0,"Heat Biologics Shares Halted On Circuit Breaker, Up 84.2%",2018-04-30 13:19:00-04:00,HTBX,positive
633731.0,42 Biggest Movers From Yesterday,2018-03-20 04:48:00-04:00,HTBX,neutral
633732.0,25 Stocks Moving In Monday's Pre-Market Session,2018-03-12 08:04:00-04:00,HTBX,neutral
633733.0,"Heat Biologics Reported Late Friday FY17 EPS $(3.08) vs $(3.50) Est., FY17 Sales $1.52M vs $1.44M Est.",2018-03-05 08:24:00-05:00,HTBX,neutral
633734.0,31 Stocks Moving In Wednesday's Pre-Market Session,2018-02-28 08:06:00-05:00,HTBX,neutral
633735.0,UPDATE: Heat Biologics Says 'combination of HS-110 and nivolumab was well tolerated',2018-02-28 06:42:00-05:00,HTBX,positive
633736.0,"UPDATE: Heat Biologics Says 'Overall responses appeared durable and long lasting. The survival data are still maturing, and median overall survival has not yet been reached'",2018-02-28 06:42:00-05:00,HTBX,negative
633737.0,"UPDATE: Heat Biologics Says 'Evaluable ITT patients...demonstrated overall response and disease control rates of 26% and 67%, respectively'",2018-02-28 06:41:00-05:00,HTBX,positive
633738.0,"Heat Biologics 8-K Shows Interim Results From Phase 2 Study Of HS-110 In Combo With Bristol's Opdivo In Patients With NSCLC: '...6 patients (17%) achieved a partial response, 14 patients (40%) achieved disease control'",2018-02-28 06:41:00-05:00,HTBX,neutral
633739.0,25 Stocks Moving In Monday's Pre-Market Session,2018-02-26 08:00:00-05:00,HTBX,neutral
633740.0,46 Biggest Movers From Yesterday,2018-02-26 05:08:00-05:00,HTBX,neutral
633741.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-02-25 15:50:00-05:00,HTBX,neutral
633742.0,40 Stocks Moving In Friday's Mid-Day Session,2018-02-23 12:26:00-05:00,HTBX,neutral
633743.0,19 Biotech Stocks With Clinical Trial Outcomes In February,2018-02-08 16:41:00-05:00,HTBX,neutral
633744.0,46 Biggest Movers From Yesterday,2018-02-01 04:46:00-05:00,HTBX,neutral
633745.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-01-31 12:24:00-05:00,HTBX,neutral
633746.0,"UPDATE: Traders Attributing Upside In Heat Biologics To Jan. 30 Release From Co. Highlighting It Will Host Analyst, Investor Day On Feb. 28 To Present Results From Phase 2 Lung Cancer Study",2018-01-31 09:45:00-05:00,HTBX,negative
633747.0,"Nano Cap, Low Float Heat Biologics Shares Spike ~22% Higher As Hearing Traders Circulate Chatroom Chatter Of A Positive Mention On Social",2018-01-31 09:40:00-05:00,HTBX,positive
633748.0,38 Biggest Movers From Yesterday,2018-01-30 04:37:00-05:00,HTBX,neutral
633749.0,"Heat Biologics Shares Resume Trade, Continue Higher, Up 24.6%",2018-01-25 10:07:00-05:00,HTBX,positive
633750.0,33 Stocks Moving In Tuesday's Mid-Day Session,2018-01-23 12:50:00-05:00,HTBX,neutral
633751.0,Heat Biologics Gives an Update Following its FDA Guidance Meeting for HS-110,2017-12-07 07:06:00-05:00,HTBX,neutral
633752.0,Heat Biologics Terminates its At Market Issuance Sales Agreement,2017-11-07 07:13:00-05:00,HTBX,positive
633753.0,Heat Biologics S-3 Filing Shows Registration For $50M Mixed Securities Shelf Offering,2017-10-30 10:18:00-04:00,HTBX,positive
633754.0,Heat Biologics Prices Rights Offering at $0.62/Share,2017-10-16 07:08:00-04:00,HTBX,neutral
633755.0,"Heat Biologics Q2 EPS $(0.09) vs $(0.10) Est., Sales $411K",2017-08-14 07:16:00-04:00,HTBX,neutral
633756.0,"Companies Holding Shareholder Meetings Today Include: Allegiant Travel Co., Bed Bath & Beyond, Delek US Holdings, Gigamon, Guess, Heat Biologics, Immunomedics, Kadmon, Patterson-UTI, Tecogen, and Time Inc",2017-06-29 09:01:00-04:00,HTBX,neutral
633757.0,13G from Sabby Mgmt on Heat Biologics Shows 9.7% Stake,2017-04-17 15:20:00-04:00,HTBX,neutral
633758.0,Watching Players in Zika Space as Hearing HHS Has Reached $8.9M Deal with Siemens Healthineers for Development of a New Zika Diagnostic Test,2017-04-12 13:22:00-04:00,HTBX,positive
633759.0,"Heat Biologics Reports Q4 EPS $(0.71) vs. $(2.53) YoY, Sales $342K",2017-03-31 07:03:00-04:00,HTBX,neutral
633760.0,Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide,2017-03-23 14:32:00-04:00,HTBX,negative
633761.0,15 Biggest Mid-Day Losers For Thursday,2017-03-23 12:56:00-04:00,HTBX,negative
633762.0,Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge,2017-03-23 12:04:00-04:00,HTBX,positive
633763.0,Mid-Morning Market Update: Markets Mostly Flat; Conagra Profit Beats Estimates,2017-03-23 10:36:00-04:00,HTBX,positive
633764.0,Heat Biologics Prices 5M Share Offering at $0.80/Share,2017-03-23 08:01:00-04:00,HTBX,positive
633765.0,"Heat Biologics Says Prelim. FY16 Loss Will Be ~$13M, Estimates Cash Of ~$7.8M",2017-03-23 07:52:00-04:00,HTBX,negative
633766.0,"Heat Biologics Announces Offering Of Common Stock, No Size Disclosed",2017-03-22 16:04:00-04:00,HTBX,negative
633767.0,10 Biggest Mid-Day Gainers For Tuesday,2017-03-21 12:40:00-04:00,HTBX,neutral
633768.0,16 Stocks Moving In Tuesday's Pre-Market Session,2017-03-21 08:52:00-04:00,HTBX,neutral
633769.0,Heat Biologics +27% Premarket @$1.18; Co Announced  Positive Interim Phase 2 Lung Cancer Results In Patients Treated With Hs-110 In Combination With A Checkpoint Inhibitor,2017-03-21 07:10:00-04:00,HTBX,negative
633770.0,Heat Biologics Reports Interim Phase 2 ELISPOT Suggests HS-110 Plays Important Role In Tumor Reduction And May Enhance Efficacy Of Checkpoint Inhibitors In Lung Cancer Patients,2017-03-21 07:06:00-04:00,HTBX,negative
633771.0,Heat Biologics Reports Florida Dept. of Health Awards Co. 3-Year Grant to Develop gp96-Based Zika Vaccine,2017-03-16 07:16:00-04:00,HTBX,positive
633772.0,Heat Biologic Announces Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine,2017-03-16 07:15:00-04:00,HTBX,positive
633773.0,Mid-Afternoon Market Update: Nobilis Health Drops After Q4 Results; Heat Biologics Shares Spike HIgher,2017-03-13 14:31:00-04:00,HTBX,positive
633774.0,18 Biggest Mid-Day Gainers For Monday,2017-03-13 12:51:00-04:00,HTBX,neutral
633775.0,Mid-Day Market Update: AMEC Foster Wheeler Surges Following Wood Group Bid; Aralez Pharmaceuticals Shares Plunge,2017-03-13 12:37:00-04:00,HTBX,positive
633776.0,"Several Biotherapeutics Stocks Outperforming: Cerulean Pharma Up 44%, Adaptimmune 16%, Aurinia 15%, Versatem 14.5%, Heat Biologics 14%, Calithera 14%",2017-03-13 10:54:00-04:00,HTBX,neutral
633777.0,Mid-Morning Market Update: Markets Mostly Lower; Intel To Buy Mobileye For $15 Billion,2017-03-13 10:03:00-04:00,HTBX,negative
633778.0,20 Stocks Moving In Monday's Pre-Market Session,2017-03-13 08:24:00-04:00,HTBX,neutral
633779.0,Heat Biologics Meets Efficacy Endpiont in Phase 1B Trial,2017-03-13 07:04:00-04:00,HTBX,neutral
633780.0,Heat Biologics To Acquire 80% Controlling Interest In Pelican For $500K In Cash  and 1.32M Shares of Heat Biologics Common Stock,2017-03-08 07:09:00-05:00,HTBX,positive
633781.0,Heat Biologics HS-110 Phase 1b Data Expected To Be Presented At Int'l Society For Study Of Lung Cancer Annual Mtg Today,2016-12-06 08:34:00-05:00,HTBX,negative
633782.0,15 Biggest Mid-Day Gainers For Friday,2016-12-02 12:41:00-05:00,HTBX,neutral
633783.0,"S-3 from Heat Biologics Shows Registration for 3.02M Shares of Common Stock, Warrants",2016-12-01 17:07:00-05:00,HTBX,positive
633784.0,Mid-Afternoon Market Update: NASDAQ Down 1.25%; CLARCOR Shares Gain On Acquisition News,2016-12-01 14:22:00-05:00,HTBX,positive
633785.0,12 Biggest Mid-Day Losers For Thursday,2016-12-01 13:09:00-05:00,HTBX,negative
633786.0,Mid-Day Market Update: Crude Oil Up Over 4%; Express Shares Fall On Weak Outlook,2016-12-01 12:33:00-05:00,HTBX,negative
633787.0,Mid-Morning Market Update: Markets Mostly Higher; Dollar General Profit Misses Views,2016-12-01 10:10:00-05:00,HTBX,positive
633788.0,"Heat Biologics Cools Off, Bluebird Bio Heats Up",2016-12-01 09:54:00-05:00,HTBX,neutral
633789.0,22 Stocks Moving In Thursday's Pre-Market Session,2016-12-01 08:30:00-05:00,HTBX,neutral
633790.0,Heat Biologics -57% Premarket @$1.24; HS-410 Phase II Topline Data Showed No Statistically Significant Difference In Primary Endpoint vs Placebo,2016-12-01 06:54:00-05:00,HTBX,negative
633792.0,Heat Biologics Phase 2 Data On HS-410 To Be Presented At Society Of Urological Oncology Annual Meeting Today,2016-11-30 08:34:00-05:00,HTBX,neutral
633793.0,12 Biggest Mid-Day Gainers For Monday,2016-11-28 12:47:00-05:00,HTBX,neutral
633794.0,16 Stocks Moving In Monday's Pre-Market Session,2016-11-28 08:24:00-05:00,HTBX,neutral
633795.0,Heat Biologics +22.89% Premarket @$3.06,2016-11-28 08:08:00-05:00,HTBX,neutral
633796.0,12 Biggest Mid-Day Gainers For Friday,2016-11-25 12:07:00-05:00,HTBX,neutral
633797.0,Heat Biologics Shares Continue Higher (Up 22%) on Heavy Volume Fri. Following 27% Run-Up on Wed. as $1.50 Resistance Level Breached; BZ NOTE: Co. Announced Last Thursday It will Be Reporting Phase Ib Results for HS-110 In Combo with Bristol's Opdivo Dec. ,2016-11-25 11:39:00-05:00,HTBX,positive
633798.0,20 Stocks Moving In Friday's Pre-Market Session,2016-11-25 08:30:00-05:00,HTBX,neutral
633799.0,"Heat Biologics Reports Q3 Loss/Share $0.08 vs Est Loss/Share $0.15, Revenue $220,233K",2016-11-10 16:48:00-05:00,HTBX,neutral
633800.0,"Heat Biologics CEO Interview Abuzz With Zika Developments: Collaboration, Vaccine And Other Initiatives",2016-10-31 13:54:00-04:00,HTBX,neutral
633801.0,Heat Biologics Reports Remains On Track to Achieve Multiple Topline Data Readouts This Qtr.,2016-10-13 07:06:00-04:00,HTBX,neutral
633802.0,Here's Why Heat Biologic Shares Are Hot This Morning,2016-10-12 11:58:00-04:00,HTBX,positive
633803.0,Heat Biologics Up 17.65% On PR Earlier This Morning Highlighting Advancement Of Biomarker Discovery Partnership With Adaptive Biotechnologies,2016-10-12 09:23:00-04:00,HTBX,neutral
633804.0,Heat Biologics Says Paid Down $1.5M of Debt,2016-10-07 07:01:00-04:00,HTBX,negative
633805.0,Heat Biologics Reports Resumption of Enrollment in Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combo with Anti-PD-1 Checkpoint Inhibitor,2016-09-14 07:01:00-04:00,HTBX,negative
633806.0,"After-Hours Losers Aug. 15, '16: HAIN Down 25%, HTBX 17%, EVOK 7%, DAVE 3%, GBDC 2.7%, CXO 1.8%, ALRM 1.3%",2016-08-15 17:59:00-04:00,HTBX,negative
633807.0,Heat Biologics Reports Q2 Loss/Share $(0.17),2016-08-15 16:42:00-04:00,HTBX,neutral
633808.0,Heat Biologics Reports Q2 EPS $(0.17) vs. Est. $(0.27),2016-08-15 16:35:00-04:00,HTBX,neutral
633809.0,Heat Biologics Suspends Planned Public Offering,2016-07-22 15:51:00-04:00,HTBX,neutral
633810.0,12 Biggest Mid-Day Losers For Friday,2016-07-22 13:11:00-04:00,HTBX,negative
633811.0,15 Stocks Moving In Friday's Pre-Market Session,2016-07-22 08:30:00-04:00,HTBX,neutral
633812.0,Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock,2016-07-22 08:01:00-04:00,HTBX,neutral
633813.0,Heat Biologics Announces Proposed Public Offering of Common Stock,2016-07-21 16:25:00-04:00,HTBX,neutral
633814.0,"Heat Biologics Announces ""Cancer Immunology Research"" Publication Featuring its ComPACT Platform Technology",2016-07-07 07:03:00-04:00,HTBX,negative
633815.0,Roth Capital Initiates Coverage on Heat Biologics at Buy,2016-06-20 08:06:00-04:00,HTBX,neutral
633816.0,Heat Biologics Releases Updated Slide Presentation,2016-06-06 07:10:00-04:00,HTBX,neutral
633818.0,Heat Biologics Reports Q1 EPS $(0.50) vs $(0.56) Est.,2016-05-11 07:03:00-04:00,HTBX,neutral
633819.0,Heat Biologics Reports Q1 EPS $(0.50) vs. Est. $(0.56),2016-05-11 07:01:00-04:00,HTBX,neutral
633820.0,Franklin Resources Reports 7.6% Stake In Heat Biologics As Of March 31,2016-04-07 17:18:00-04:00,HTBX,neutral
633821.0,"Heat Biologics Reports Cost-Saving Measures, Focused Strategy: Enable Co. to Achieve Phase 2 HS-410 Bladder Cancer Data Readout in Q4'16 with Current Cash On Hand",2016-04-07 07:03:00-04:00,HTBX,positive
633823.0,Michael Kharitonov Reports 9.13% Stake in Heat Biologics in 13D,2016-03-24 06:15:00-04:00,HTBX,neutral
633824.0,Mid-Morning Market Update: Markets Open Higher; Tiffany Q4 Profit Beats Views,2016-03-18 10:03:00-04:00,HTBX,positive
633825.0,Heat Biologics Offering 9.10M Shares At $0.75/Shr,2016-03-18 08:31:00-04:00,HTBX,positive
633826.0,"Heat Biologics S-1 Effectiveness Date:	March 17, 2016 5:30 P.M. -Filing",2016-03-18 06:30:00-04:00,HTBX,neutral
633827.0,Heat Biologics Haled on Single-Stock Circuit Breaker,2016-03-17 15:33:00-04:00,HTBX,neutral
633828.0,Heat Biologics Spokesperson Says No News to Account for Move in Share Price; Says they are Looking into It,2016-03-17 10:35:00-04:00,HTBX,neutral
633829.0,Heat Biologics Halted on Circuit Breaker at High $1.25,2016-03-17 09:58:00-04:00,HTBX,neutral
633830.0,Heat Biologics Resumes Trading; Now Up 55%,2016-03-17 09:53:00-04:00,HTBX,neutral
633831.0,Heat Biologics Halted on Circuit Breaker,2016-03-17 09:50:00-04:00,HTBX,neutral
633832.0,Heat Biologics Says No Longer Enrolling New Patients In Monotherapy Trial Arm Due To The Current Availability Of Standard Of Care BCG; Says No Safety Concerns Related to HS-410; All Enrolled Patients to Continue Treatment,2016-02-25 07:14:00-05:00,HTBX,positive
633833.0,Heat Biologics Reports FY15 EPS $(2.53) vs. Est $(2.30),2016-02-18 07:10:00-05:00,HTBX,neutral
633834.0,Cantor Fitzgerald Downgrades Heat Biologics to Speculative Buy,2016-02-04 07:16:00-05:00,HTBX,positive
633835.0,Heat Biologics Places HS-410 Phase 2 Trial on Partial Hold,2016-02-03 07:07:00-05:00,HTBX,neutral
633836.0,"Heat Biologics To Show Interim Result in In Ongoing Phase 2 Cancer Trial, Early Results Support Mechanism; 6 of 7 Recurrence Free After 3-Months",2016-01-26 07:17:00-05:00,HTBX,positive
633837.0,Heat Biologics Appoints Timothy Creech as CFO,2015-12-01 07:01:00-05:00,HTBX,neutral
633838.0,Heat Biologics Reports HS-410 Phase 1 Bladder Cancer Trial Results at the Society for Immunotherapy of Cancer Annual Meeting,2015-11-06 07:02:00-05:00,HTBX,negative
633839.0,Heat Biologics Completes Patient Enrollment for Randomized Arms of Its Phase 2 HS-410 Bladder Cancer Trial,2015-10-08 07:01:00-04:00,HTBX,negative
633840.0,Heat Biologics to Present New Data on Its ComPACT Platform at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference,2015-09-16 09:04:00-04:00,HTBX,negative
633841.0,Heat Biologics Reports Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC,2015-09-01 07:01:00-04:00,HTBX,negative
633842.0,Heat Biologics Reports Q2 Loss $0.56 vs est Loss $0.47,2015-08-13 08:02:00-04:00,HTBX,negative
633843.0,Heat Biologics Names Dr. Taylor Schreiber Chief Scientific Officer,2015-07-27 08:05:00-04:00,HTBX,neutral
633844.0,Heat Biologics Reports Development of ComPACT,2015-06-15 07:12:00-04:00,HTBX,neutral
633845.0,"Heat Biologics, Inc. to Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 in Advanced NSCLC at ASCO",2015-05-29 08:02:00-04:00,HTBX,positive
633846.0,Benzinga's Top Initiations,2015-05-26 09:38:00-04:00,HTBX,positive
633847.0,H.C. Wainwright Initiates Heat Biologics At Buy,2015-05-26 08:55:00-04:00,HTBX,neutral
633848.0,"H.C. Wainwright Initiates Coverage on Heat Biologics at Buy, Announces $13.00 PT",2015-05-26 07:16:00-04:00,HTBX,neutral
633849.0,Heat Biologics Q1 EPS -$0.57 vs -$0.49 est,2015-05-14 08:03:00-04:00,HTBX,neutral
633850.0,Heat Biologics Initiates Phase 1b Trial of Viagenpumatucel-L in Non-Small Cell Lung Cancer,2015-05-11 08:08:00-04:00,HTBX,negative
633851.0,Morning Market Losers,2015-03-11 09:46:00-04:00,HTBX,negative
633852.0,Benzinga's Top #PreMarket Losers,2015-03-11 08:17:00-04:00,HTBX,negative
633853.0,US Stock Futures Signal Higher Start On Wall Street,2015-03-11 07:39:00-04:00,HTBX,neutral
633854.0,Heat Biologics Prices 1.64M Share Offering @$6.50/Share,2015-03-11 04:41:00-04:00,HTBX,positive
633855.0,Heat Biologics CFO Czajkowski To Resign,2015-03-10 17:19:00-04:00,HTBX,negative
633856.0,Heat Biologics Announces Proposed Offering Of Common Shares,2015-03-10 17:09:00-04:00,HTBX,positive
633857.0,Morning Market Gainers,2015-03-09 09:43:00-04:00,HTBX,neutral
633858.0,Heat Biologics Receives FDA Fast Track Designation For HS-410 Treatment,2015-03-09 08:04:00-04:00,HTBX,neutral
633859.0,US Stock Futures Mostly Flat; FOMC Minutes In Focus,2015-02-18 07:37:00-05:00,HTBX,neutral
633860.0,"OncoSec Medical, Heat Biologics Announce Collaboration to Evaluate Combination of Immunotherapy Platforms",2015-02-18 06:13:00-05:00,HTBX,neutral
633861.0,Heat Biologics Presents Positive Preclinical Data At Keystone Symposia,2015-02-11 08:04:00-05:00,HTBX,positive
633862.0,Heat Biologics  Announces 2015 Corporate Objectives,2015-02-02 08:04:00-05:00,HTBX,neutral
633863.0,"Heat Biologics, Inc. Presents Positive Immunological Data on HS-410 in Non-Muscle Invasive Bladder Cancer at the 7th Annual Phacilitate Immunotherapy Forum 2015",2015-01-26 08:12:00-05:00,HTBX,negative
633864.0,Heat Biologics Reports Q3 EPS of $(0.46) vs $(0.42) Est,2014-11-14 07:31:00-05:00,HTBX,neutral
633865.0,"Heat Biologics, Inc. Commences Patient Dosing Of Phase 2 Clinical Study Of Vesigenurtacel-L For The Treatment Of Bladder Cancer",2014-10-27 08:11:00-04:00,HTBX,negative
633866.0,S-3 from Heat Biologics Shows Registration for $50M Mixed Securities Shelf Offering,2014-10-10 17:04:00-04:00,HTBX,positive
633867.0,Heat Biologics Completes Enrollment of Phase 1 Clinical Trial of Vesigenurtacel-L for Treatment of Bladder Cancer,2014-10-02 07:39:00-04:00,HTBX,negative
633868.0,Heat Biologics Commences Patient Dosing In Phase 2 Study Of Viagenpumatucel-L For The Treatment Of Non-Small Cell Lung Cancer,2014-09-18 08:06:00-04:00,HTBX,negative
633869.0,Heat Biologics Reports Q2 EPS of $(0.44) vs $(0.40) Est,2014-08-14 07:06:00-04:00,HTBX,neutral
633870.0,"UPDATE: Heat Biologics Amends Phase 2 Trial, Will Allow Phase 2 Trails More Quickly After Phase 1",2014-08-04 08:08:00-04:00,HTBX,positive
633871.0,Heat Biologics Reports Amendment of Bladder Cancer Protocol for Early Advance Into Phase 2 Clinical Trial,2014-08-04 08:07:00-04:00,HTBX,negative
633872.0,Heat Biologics CEO Says Market Cap Undervauled; Company's Progress Not Reflected in Share Price =8-K,2014-06-30 07:21:00-04:00,HTBX,positive
633873.0,"Heat Biologics Announces Has Received Green Light, Will Expand Enrollment of Phase 1/2 Study of HS-410 in Bladder Cancer",2014-05-30 08:07:00-04:00,HTBX,negative
633874.0,Heat Biologics Reports Q1 EPS of $(0.36) vs $(0.39) Est,2014-05-13 07:36:00-04:00,HTBX,neutral
633875.0,Heat Biologics Reports Successful Closing of Manufacturing of HS-410,2013-11-25 08:34:00-05:00,HTBX,positive
633876.0,Heat Biologics Files IND for Bladder Cancer Product Candidate,2013-10-01 08:05:00-04:00,HTBX,negative
633877.0,"Aegis Capital Initiates Coverage on Heat Biologics at Buy, Announces $36.00 PT",2013-09-23 11:36:00-04:00,HTBX,neutral
633878.0,"Aegis Capital Initiates Coverage on Heat Biologics at Buy, Announces $36.00 PT",2013-09-18 08:57:00-04:00,HTBX,neutral
633879.0,"Canaccord Genuity Initiates Coverage on Heat Biologics at Buy, Announces $15.00 PT",2013-09-03 08:32:00-04:00,HTBX,neutral
633880.0,"Heat Biologics, Inc. Announces Closing of Initial Public Offering of 2,500,000 Shares of Common Stock At $10.00 Per Share",2013-07-29 12:00:00-04:00,HTBX,positive
633881.0,Stocks Hitting 52-Week Lows,2013-07-29 10:11:00-04:00,HTBX,negative
633882.0,Heat Biologics Shares Open for Trade at $10,2013-07-24 10:21:00-04:00,HTBX,positive
633883.0,"Shares of Heat Biologics Now Open for Quote, IPO Expected to Open at 10:20AM EDT, Priced 2.5M Shares at $10/Share",2013-07-24 10:07:00-04:00,HTBX,positive
633884.0,Heat Biologics Prices IPO of 2.5M Shares at $10/Share,2013-07-23 18:22:00-04:00,HTBX,positive
633885.0,"Heat Biologics Sets IPO of ~2.27M at $10-12/Share Range, Aegis Capital, Cantor Fitzgerald Named Underwriters",2013-07-10 13:27:00-04:00,HTBX,neutral
